MedPath

Glycemic Response in Persons With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: Oral Nutrition Supplement
Registration Number
NCT04168541
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This will be a randomized crossover design. The subjects will be randomized to one of six interventions on six separate study days, one week apart.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Oral Nutrition Supplement EOral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement FOral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement BOral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement DOral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement AOral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement COral Nutrition SupplementProduct containing calories from carbohydrate, protein, and fat
Primary Outcome Measures
NameTimeMethod
Area under the blood glucose curve (ACU 0-240 minutes)Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
Secondary Outcome Measures
NameTimeMethod
Insulinogenic index [Change in Ins30/Change in Glu30][Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]
Area under the insulin curves (AUC 0-240)Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Trial Locations

Locations (1)

Orange County Research Center

🇺🇸

Tustin, California, United States

© Copyright 2025. All Rights Reserved by MedPath